Latest news
Loading news…
Corvidia Therapeutics focuses on the research and development of transformative therapies for cardio-renal diseases.
Corvidia was acquired by Novo Nordisk in 2020 for $725M.
Total Funding
Available in Pro Last Funding
Available in Pro Acquisitions
0
Monthly Visits
Available in Pro Contacts
6
Company Details
Funding & Financials
Pro- Total funding
- Funding rounds
- Last funding
- Last funding type
- Last funding date
- Funding status
- Total equity funding
- Revenue range
Web Traffic
Pro- Monthly visits
- Global traffic rank
- 6-mo avg visits
- Visit duration (s)
- Pages / visit
- Bounce rate
- Rank change (mo)
Company Info
- Org types
- company
- HQ
- Waltham, Massachusetts, United States
Key People at Corvidia
Chairman of the Board of Directors
6
professional contacts at Corvidia
Contact execs at Corvidia →Explore 200,000+ acquisitions — free
Filter the full database across sectors, companies, dates, and deal sizes. No signup, no paywall.
Recent News related to Corvidia
Loading news…
FAQs about Corvidia
People who checked this page also checked these
Browse the full Acquirezy directory.